Report : Asia Pacific E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging); End User (Commercial or Private Labs, Physician Offices, Hospitals, Public Health Labs, and Academic Research Institutes), and Country - Regional Analysis and
Monoclonal Antibodies Segment Held Largest Share of E. coli Testing Market in 2019
According to our new market research study on “Asia Pacific E. coliTesting MarketForecast to 2027 - Covid-19 Impact and Regional Analysis by Technology,and End-User”the market is expected to reach US$ 496.7 Mn by 2027 from US$ 283.2 Mn in 2019; it is estimated to grow at a CAGR of 7.4% from 2020 to 2027. The report provides trends prevailing in the Asia PacificE. coliTestingmarket and the factors driving the market growth along with those hindering it.
Based on technology, the monoclonal antibodies segment accounted for the largest share of the E. coli testing market in 2019. However, the immunoassays segment is estimated to grow at the highest CAGR during the forecast period. Monoclonal antibodies offer advantages such as low cross-reactivity, high specificity, and excellent lot-to-lot stability, which are likely to contribute to the dominancy of the segment during the forecast period. Whereas, the rising adoption of immunotherapy for E. coli testing and increased reagents offering by companies are likely to serve wider growth opportunities during forecast period.
The growth of the Asia PacificE. colitesting marketis mainly attributed to increasing E. coli testing, growing product innovation, and rising research activities are expected to offer growth opportunities for the players operating in the market. However, thetesting challengesis the major factor hindering the market growth in Asia Pacific.
A few of the leading companies operating in the Asia PacificE. colitestingmarket are bioMerieux SA, Abbott (Alere Inc.), BD, Thermo Fisher Scientific, Inc., and Hologic, Inc.
Asia Pacific E. Coli Testing Market, By Country, 2019 (%)
The report segments Asia PacificE. Coli Testing marketas follows:
Asia PacificE. Coli Testing Market– ByTechnology
- Monoclonal Antibodies
- Differential Light Scattering
- Molecular Diagnostics
- Immunoassays
- Chromatography
- Flow Cytometry
- Gel Microdroplets
- Diagnostic Imaging
Asia PacificE. Coli Testing Market – ByEnd-User
- Commercial or Private Labs
- Physician Offices
- Hospitals
- Public Health Labs
- Academic Research Institutes
Asia PacificE. Coli Testing Market– By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia